Now Available: JBJS Supplement on the Secondary Analyses from the PARITY Trial
An international team of musculoskeletal oncology experts have explored several important questions regarding the surgical treatment of patients through secondary …
What’s New in Musculoskeletal Infection 2023
The new JBJS Guest Editorial “What’s New in Musculoskeletal Infection” presents findings related to chronic periprosthetic joint infection, …
Toward a Deeper Understanding of Disparities in Health-Related Outcomes
A new study evaluates sociodemographic factors impacting racial and ethnic disparities in baseline PROM scores of foot and ankle patients. …
Elite Reviewer Spotlight: Sokratis E. Varitimidis
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their …
A Year in Review: The 2022-23 JBJS Robert Bucholz Resident Journal Club Support Program
Journal clubs that received JBJS funding support in October 2022 had much to say about their year of meetings. Here …
Shoulder Instability and Osteoarthritis: New Biological Insight
A new JBJS study presents novel data on gene expression in glenoid cartilage following shoulder instability. JBJS Deputy Editor for …
JBJS EST Awards: 2022 Winners Announced
OrthoBuzz is pleased to highlight the winners of the JBJS Essential Surgical Techniques (EST) Editor’s Choice Awards for 2022. Two …
What’s New in Orthopaedic Trauma 2023
Recent findings on fracture management and other trauma-related topics are presented in the new JBJS Guest Editorial “What’s New …